MarketInOut Stock Screener Log In | Sign Up
 

enVVeno Medical Corp

NASDAQ • Healthcare • Medical Devices • Quote as of 10/23/2026
enVVeno Medical Corp stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization5.09 mln
Float0.67 mln
Earnings Date11/05/2026

Piotroski F-Score

3 / 9
Below average

Relative Strength

9 / 100
Severely lagging

Debt / Equity

0.02
Debt-free

ROE

-58.65
Deeply negative

ROA

-53.39
Deeply negative

Business Description

enVVeno Medical Corporation is a California-based company working to improve how venous disease is treated through the development of replacement venous valves. Its primary product, the VenoValve, is surgically implanted into the femoral vein to treat chronic venous insufficiency. The company is also developing the enVVe, a catheter-based valve system that offers a less invasive alternative. Founded in 1999 and formerly known as Hancock Jaffe Laboratories, enVVeno Medical is headquartered in Irvine, California.

Key Fundamentals

EPS-23.79
ROE-58.65
ROIC-983
ROA-53.39
EBITDA, mln-15.33
EV / EBITDA1.02
EV / EBIT0.99

Quote Details

Last 6.65
Change -0.26 (-3.76%)
Open 6.72
Volume 7,738
Turnover 51,458
Average Volume 37,203

Financial Ratios

Leverage Ratio1.10
Current Ratio11.70
Price / Book0.25
Price / Tangible Book0.25
Debt / Equity0.02

Financial Strength

Piotroski F-Score 3 / 9
Short Ratio0.47
Short % of Float1.96

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -10.98% 8 / 100   
1 Month -26.84% 13 / 100   
2 Months -39.71% 11 / 100   
6 Months -48.65% 13 / 100   
1 Year -75.38% 10 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog